Literature DB >> 2492148

The effect of continuous or pulsatile administration of oxytocin to ewes at 126 to 136 days' gestation on myometrial activity and fetal oxygenation.

G Pimentel1, E R Poore, P W Nathanielsz.   

Abstract

Oxytocin was infused either continuously or in pulses to pregnant ewes to compare the responses of myometrial activity (contractures) and changes in fetal arterial PO2. Group 1 (n = 5) was infused with saline solution throughout the experiment. In group 2 (n = 5) oxytocin was infused continuously (160 microU.kg-1.min-1) for 7 days whereas group 3 (n = 5) ewes received 960 microU.kg-1.min-1 for 5 minutes every 30 minutes for 7 days. Contracture frequency increased in both oxytocin-infused groups. With continuous infusion contracture frequency returned to preinfusion levels during the last 4 days of infusion, whereas the pulsatile infusion contracture frequency remained increased throughout the infusion period. Fetal arterial PO2 was decreased throughout the 7 days of infusion in both oxytocin-infused groups. Pulsatile group fetal arterial PO2 levels remained decreased after the oxytocin infusion was stopped. These findings show: (1) Myometrial response to oxytocin in late pregnant ewes is influenced by the mode of administration; (2) administration of oxytocin to pregnant ewes resulted in a decrease in fetal PO2, and thus fetal hypoxemia cannot be attributed exclusively to increased contracture frequency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492148     DOI: 10.1016/0002-9378(89)90129-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Pulsatile secretion of oxytocin during parturition in the pig: temporal relationship with fetal expulsion.

Authors:  C L Gilbert; J A Goode; T J McGrath
Journal:  J Physiol       Date:  1994-02-15       Impact factor: 5.182

Review 2.  Arginine Vasopressin and Copeptin in Perinatology.

Authors:  Katrina Suzanne Evers; Sven Wellmann
Journal:  Front Pediatr       Date:  2016-08-02       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.